AstraZeneca Pharmaceuticals LP
CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of[...]
Regeneron Pharmaceuticals Inc.
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in[...]
05/17/2023 | Press release | Distributed by Public on 05/17/2023 02:08
Please select the service you want to use:
Smartlinks | CURIA - Court of Justice of the European Union | News | Crime and Judiciary | Judiciary | International News | International Courts and Tribunals | Politics and Policy | Policy and Regulation | Government | National Government | International Policy | International Governmental Organizations (IGO) | International Courts and Tribunals | Financial Statement | Judiciary | Courts and Tribunals | EU Institutions
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact